NYSE · LLY
Eli Lilly and Company
$1,417.54+$43.84 (+3.19%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.22% below the high.
Loading market information…
CNQ · IWIN.CN · CAD
Stock price, earnings
Quote as of Jul 12, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Irwin Naturals Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Irwin Naturals Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Irwin Naturals Inc., headquartered in Los Angeles, California, is a firm specializing in herbal supplements. This company distributes its range of CBD products both within the United States and across international markets. Consumers can acquire its offerings via its online platform or through a vast network of roughly 100,000 retail stores. The enterprise was formerly recognized as Datinvest International Ltd.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:45 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,417.54+$43.84 (+3.19%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.22% below the high.
$273.20-$2.00 (-0.73%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 3.12% below the high.
CA$0.01CA$0.00 (0.0%)
SLANG Worldwide Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.07CA$0.00 (0.0%)
Enlighta Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.36% below the high.
CA$0.01-CA$0.01 (-50.0%)
Trees Corporation’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.01$0.00 (0.0%)
Maple Leaf Green World Inc.’s quoted price sits in the lower half of its reported 52-week range, 92.86% below the high.
$0.00$0.00 (0.0%)
TransCanna Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Cognetivity Neurosciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 94.74% below the high.
